MedX Health Corp (MDX.V)

0.0350 -0.0050 (-12.50%) At close: 02:14PM EDT

MedX Health Corp

1495 Bonhill Road
Unit #1
Mississauga, ON L5T 1M2
Canada
905-670-4428
https://medxhealth.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Louie Canitano	COO & MD of Light Therapy Products	126.52k	N/A	N/A
Mr. Michael Druhan	Pres of Dermatological Services & Products	250k	N/A	N/A
Mr. Naman Demaghlatrous BAMA	Pres, CEO & Director	N/A	N/A	N/A
C H Freeman	Interim Chief Financial Officer	N/A	N/A	N/A
Mr. Paul Karam	Sales and Marketing Director of Europe, Middle East & Africa	N/A	N/A	N/A
Dr. Daniel A. Kaute	Managing Director of Europe	N/A	N/A	N/A
Mr. Scott Naughton	Managing Director of US Operations	N/A	N/A	N/A
Mr. Christopher H. Freeman	Sec.	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

MedX Health Corp, a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, SIMSYS, and MoleMate, which creates real-time images for physicians and dermatologists to evaluate various types of moles or lesions within seconds. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

Corporate Governance

MedX Health Corp’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.